A statistically significant hypermethylation of the PLA2R1 promoter was detected in both Grade II (fold change = 1.034, p < 0.0001) and Grade III (fold change = 1.279, p < 0.0001) breast cancers compared to benign breast tissues (Figure 3C). This evidence concerns the gene PLA2R1 and breast cancer.